Metformin for PCOS/PMOS

If you have recently been diagnosed with polycystic ovary syndrome (PCOS) (also called polyendocrine metabolic ovarian syndrome (PMOS) in recent medical literature), there is a real chance you walked out of your doctor's office with a prescription for metformin in your hand. You may have looked at the label, seen "a medication used to treat type 2 diabetes," and wondered if there was a mistake. Why is a blood sugar drug being prescribed for a condition you came in about because your periods stopped, your jawline broke out, or your scalp started thinning?

The reason sits at the center of how the medical community now understands PCOS. Insulin resistance is by far the most common root cause: at least 80 percent of women with PCOS have some level of it. The 2026 international consensus rename to PMOS was driven partly by exactly this fact: this is a multisystem metabolic-endocrine condition, not a localized issue with ovarian "cysts" (Teede et al. 2026). Metformin is the leading insulin-sensitising drug, and it can be really helpful in treating this root cause for some women.

Whether or not to use metformin for your PCOS is a personal choice to make with your doctor. You can achieve the same results, if not better, by following the diet and lifestyle changes in my book, The PCOS Repair Protocol. The 2023 Monash International Evidence-based Guideline says metformin should be considered for weight and metabolic health in adults with PCOS and a BMI of 25 or more, and could be considered below that (Teede et al. 2023).

Why is a diabetes medication being prescribed for a hormonal condition?

Metformin is prescribed for PCOS because of insulin. If you have high levels of insulin for a long time, it triggers your ovaries to start producing extra testosterone and other androgens, and metformin brings your insulin down.

Insulin resistance starts long before your fasting blood sugar ever looks abnormal on a standard lab test. Your muscle and fat cells stop responding to insulin the way they should. Because insulin is the signal that tells those cells to pull glucose (sugar) out of your bloodstream, your body senses that the sugar is sitting locked outside the cells, and your pancreas compensates by pumping out significantly more insulin to force the doors open and maintain a normal blood sugar reading.

For a while, this works. Your blood sugar stays normal. But the cost is a steadily rising level of insulin circulating in your bloodstream, and that high circulating insulin is where most PCOS symptoms actually originate.

High insulin acts as a direct amplifier on your reproductive hormones. It travels to your ovaries and hyper-stimulates the cells there to overproduce androgens like testosterone (Diamanti-Kandarakis & Dunaif 2012). At the same time, it travels to your liver and suppresses the production of sex hormone-binding globulin (SHBG), a protein in your blood that normally binds up loose testosterone so it cannot freely drive symptoms (Goodarzi et al. 2011). When SHBG drops, more testosterone is biologically active.

That free testosterone is what physically slows the normal development of your ovarian follicles, causing you to miss ovulation and skip periods. It is what drives the cystic acne along your jawline. It is what shrinks the hair follicles on your scalp into the diffuse thinning pattern that shows up in PCOS.

PCOS (or PMOS, in the framing the 2026 international consensus moved toward) also confers a significantly elevated risk of insulin resistance independent of your body weight (Randeva et al. 2012). Women at a normal BMI can still carry the upstream metabolic driver. This is why managing the insulin is so often the most effective way to manage the testosterone.

That is where metformin comes in.

How exactly does metformin work in your body?

Metformin helps to improve your body's sensitivity to insulin. It works entirely on your metabolic pathways to lower your circulating insulin demand, and the hormonal improvements come downstream of that. It does not contain hormones, it does not directly bind to androgen receptors, and it does not artificially force a bleed the way the combined birth control pill does.

When you take metformin, it activates a specific cellular energy sensor in your cells called AMP-activated protein kinase (AMPK). AMPK is essentially the switch your cells flip when they need to conserve and burn fuel more efficiently. Activating it does two things that matter for PCOS:

First, it tells your liver to stop manufacturing and releasing so much extra glucose into your bloodstream between meals. Your liver runs a process called hepatic gluconeogenesis ("liver-made-from-scratch sugar production") that normally tops up your blood sugar when you have not eaten in a while. In PCOS, this process tends to run higher than it needs to, adding to the insulin load. Metformin dials it back.

Second, it helps your skeletal muscles pull glucose out of your bloodstream without needing as much insulin to do it. The cells essentially open up extra doors for sugar to come in, so your pancreas does not have to surge insulin to force the regular doors open.

The combined effect: your blood sugar gets handled with less insulin in circulation. When your insulin levels drop, the excessive stimulation on your ovarian cells stops, and your liver is freed to start manufacturing that protective SHBG protein again.

By resolving the underlying high-insulin state, metformin can lower testosterone in insulin-resistant women by as much as 50 percent. That is the mechanism behind every visible PCOS symptom improvement you might see on metformin: it is not the drug touching your skin or your scalp or your ovaries directly; it is the drug clearing the metabolic amplifier driving those symptoms.

What symptoms does metformin actually improve?

Metformin's benefits show up in your cycle and your skin: it can regulate your menstrual cycle, bring back natural ovulation and lighten the dark skin patches that come with severe insulin resistance, and it does this over a few months. Because it works upstream at the metabolic level, this is not a medication that clears your skin within a week or restarts your period this month. It is a medication that changes the hormonal environment your follicles and your skin and your scalp are responding to, and those tissues operate on their own timelines.

If you have severe insulin resistance, you may carry a visible marker on your skin: dark, velvety patches on the back of your neck, in your armpits, or in the groin folds. This is called acanthosis nigricans, and it happens when massive amounts of circulating insulin force skin cells in body folds to multiply rapidly. As metformin lowers your insulin burden, these dark patches gradually soften and lighten. That visible change is one of the cleaner signals that the systemic metabolic driver is actually resolving.

Internally, as your free testosterone falls and SHBG rises, the environment inside your ovaries becomes less hostile to follicle development. Many women find that their menstrual cycles slowly begin to regulate and natural ovulation returns after a few months of consistent metformin use. The ovarian follicle takes approximately 100 days to mature from initial recruitment to ovulation, meaning the follicle ovulating this month was bathed in the hormonal environment of three months ago. If you start metformin today and your insulin labs improve in a few weeks, your cycle and your skin will not reflect that change until roughly 90 to 100 days from now.

Metformin is largely ineffective as a direct treatment for hirsutism (the unwanted facial or body hair growth that comes with PCOS). If severe male-pattern hair growth is your primary distress, lowering insulin alone is rarely enough to reverse the terminal hair follicles that have already developed. You will typically need targeted antiandrogen therapy or direct hair removal alongside metabolic management for the hair growth specifically.

What is the standard metformin dose, and how is it adjusted?

Standard metformin dosing starts low, often 500 mg once a day with your largest meal, and is ramped gradually over several weeks to a therapeutic range between approximately 1,000 and 1,700 mg per day, sometimes higher depending on your specific metabolic bloodwork and tolerability. It starts low because more than 50 percent of women report gastrointestinal side effects (nausea, diarrhoea and vomiting), and those side effects are the single biggest reason women discontinue metformin before it has had a chance to work.

The ramp matters more than the final number. Jumping straight to a therapeutic dose guarantees significant digestive upset; ramping slowly lets your gut adapt.

Two practical principles consistently make metformin more tolerable:

Take it with food, not on an empty stomach. Taking metformin in the middle of a meal (rather than before or after) significantly reduces the digestive upset for most women. The food provides a buffer that slows absorption and dampens the gut-side effects.

Ask about the extended-release version. Many doctors will preferentially prescribe metformin extended-release (often labeled XR or ER) rather than the standard immediate-release tablet. The XR formulation dissolves more slowly in the digestive tract and is generally much better tolerated by women who experience severe cramping or diarrhea on the standard immediate-release version. If your first prescription was immediate-release and the GI side effects are forcing you to consider stopping, ask whether switching to XR is appropriate before you give up on the medication.

If you push through the initial adjustment period (typically two to four weeks) the digestive symptoms usually subside as your body adapts. Some women never tolerate metformin well; for others, the side effects resolve and the medication becomes routine.

For your specific dose, the timing, and the duration of the ramp: those decisions belong with the doctor who is monitoring your labs and your symptoms.

While you take metformin, avoid alcohol: metformin raises your risk of lactic acidosis, and alcohol raises it further.

Why do you need to monitor your vitamin B12 on metformin?

Metformin is well known to cause vitamin B12 deficiency, so if you are using it to manage your insulin levels, I highly recommend a daily B12 supplement.

Long-term metformin use changes how your gut absorbs B12, specifically interfering with the absorption that normally happens in the lower part of your small intestine. Over years of use, this can lower your circulating B12 levels and, in some women, cause clinical deficiency.

This matters in PCOS for two reasons. The first is the general one: vitamin B12 is essential for nerve health, red blood cell formation, and cellular energy production. Deficiency can cause profound fatigue, brain fog, and in long-running cases, tingling or numbness in your hands and feet (peripheral neuropathy). The second reason is more specific: women with PCOS already disproportionately struggle with fatigue and sleep disturbances. Adding a medication-induced B12 deficiency on top of that baseline can make you feel exhausted in a way that has nothing to do with your hormones and everything to do with a fixable nutrient depletion.

If you are taking metformin long-term, have your serum B12 levels checked at least annually as part of your routine labs. Take your daily B12 in a bioavailable form such as methylcobalamin, which bypasses the absorption issue the medication is creating, and if a test shows you are severely deficient, talk to your doctor about a B12 injection. The supplementation does not require stopping metformin; it runs alongside it.

If you want to compare the commonly used options in one place, you can look through our range of PCOS supplements as a single collection.

This is the kind of thing that quietly creates real fatigue years into treatment and never gets connected back to the medication unless someone is looking for it. Adding the annual B12 lab to your standing PCOS bloodwork is one of the highest-leverage adjustments you can make if you are going to be on metformin for the long haul.

Is metformin safe to take during pregnancy?

Metformin does cross the placenta, and the long-term studies on offspring exposed in utero are still ongoing. If you are actively trying to conceive, or become pregnant while on metformin for metabolic management, whether to continue the medication is a decision that belongs with your obstetrician and your endocrinologist, weighing your specific pregnancy risk profile.

PCOS is a classical, independent risk factor for gestational diabetes (GDM). During a healthy pregnancy, the placenta naturally releases hormones that make the mother slightly more insulin-resistant in the second and third trimesters, a biological survival mechanism designed to keep extra glucose available in the bloodstream to feed the growing baby. If you enter pregnancy with the baseline insulin resistance that comes with PCOS, this normal pregnancy-induced shift compounds your existing metabolic dysfunction. Your pancreas often cannot keep up with the exponentially increased demand, and maternal blood sugar starts running high.

Women with PCOS have a roughly 4.43-fold increased risk of developing type 2 diabetes compared to women without the condition (Moran et al. 2010), the kind of finding that drove the PMOS rename in the first place, since the metabolic risk is at the center of what the syndrome is. Uncontrolled maternal high blood sugar during pregnancy is associated with serious complications: dangerously large birth weights, neonatal hypoglycemia after delivery, and an increased lifetime metabolic risk for the child.

Clinical observations indicate that continuing metformin therapy during pregnancy in women with PCOS can decrease the incidence of gestational diabetes, reduce excessive maternal weight gain, and lower the requirement for supplemental insulin injections compared to managing the condition with insulin therapy alone.

How does metformin compare to the natural alternatives?

If you are noticing side effects from metformin and would like to try an alternative, inositol has been shown head-to-head against metformin to achieve higher success in weight loss, restoring regular ovulation and natural pregnancy, without the side effects. Many women either cannot tolerate metformin's gastrointestinal effects, prefer to manage their metabolism through diet and supplementation, or want to layer a natural insulin sensitizer alongside the lifestyle work before adding a prescription. Two natural alternatives come up most often: berberine and inositol.

The 2018 and 2023 international evidence-based guidelines for PCOS make lifestyle changes, eating and movement that suit you, the core of managing the condition (Teede et al. 2018; Teede et al. 2023). No insulin sensitizer (natural or pharmaceutical) works the same way without that foundation in place. You cannot out-medicate a diet that is constantly spiking your blood sugar.

A 16-week randomized controlled trial in women with PCOS found that a low-glycemic-index pulse-based diet (rich in lentils, beans, and chickpeas) brought a greater drop in insulin response to a glucose drink, and better cholesterol results, than a standard healthy-eating diet (Kazemi et al. 2018). The mechanism behind that diet (keeping post-meal blood sugar curves flatter so your pancreas does not have to surge insulin) is the same upstream mechanism metformin is acting on pharmacologically.

On top of that base, two specific supplements have the strongest PCOS-specific evidence:

Berberine is a plant alkaloid extracted from species like Berberis vulgaris. A 2012 randomized controlled trial comparing berberine directly to metformin in women with PCOS in women with PCOS and insulin resistance, all also taking cyproterone acetate, found that berberine lowered fasting insulin against placebo, and against metformin it reduced waist circumference, total cholesterol and triglycerides more and raised SHBG more (Wei et al. 2012). Berberine adds to or changes the effect of metformin and many other prescription medicines, so check with your prescriber before taking them together, and leave it out if you are trying to conceive, pregnant or breastfeeding. The full picture is in our berberine for PCOS guide.

Inositol at the 40:1 ratio is the other natural insulin sensitizer with strong PCOS-specific evidence. Inositol acts as a cellular messenger that helps your insulin signaling work properly from the inside. The 40-to-1 ratio of myo-inositol to D-chiro-inositol matches what healthy ovaries maintain naturally, a ratio that gets disrupted in the high-insulin state of PCOS. In a small trial of overweight women with PCOS, the 40:1 combination changed some metabolic measures sooner than myo-inositol alone (Nordio & Proietti 2012), and inositol has very few side effects. For many women, a high-quality 40:1 inositol supplement paired with a low-glycemic-load diet provides enough metabolic correction to defer or avoid the prescription path entirely.

Mine is Cycle Regulate 40:1, the 40:1 ratio of myo-inositol to D-chiro-inositol with no filler, and because inositol works in a different way from metformin, it is considered safe to take alongside it.

The choice between these is not "natural versus medication"; it is "what does your specific metabolic picture need." Inositol is the single most important supplement I recommend for PCOS. Metformin is the prescription option your doctor may offer when lifestyle plus inositol is not enough. Berberine is a targeted intervention for women whose insulin resistance has not responded to gentler tools. For a fuller comparison of where each option sits, see our breakdown of PCOS weight loss supplements and vitamins.

What about GLP-1 medications instead of metformin?

If you are reading about metformin for PCOS in 2026, you have almost certainly also heard about semaglutide, tirzepatide, and the broader class of GLP-1 receptor agonists. These have become the most-discussed weight loss medications of the decade, and they show up increasingly in PCOS conversations.

The clinical positioning between the two classes is different. Metformin is a first-line option for managing the metabolic features of PCOS itself: the insulin resistance, the elevated testosterone driven by that insulin resistance, the cycle dysfunction downstream of both. GLP-1 medications are typically reserved for women with PCOS who also carry concurrent metabolic syndrome, type 2 diabetes, or obesity that has not responded adequately to lifestyle modification and metformin. They are an escalation, not a replacement for the first-line tools.

The two classes also act differently. Metformin primarily reduces hepatic glucose output and improves peripheral insulin sensitivity through AMPK activation, lowering the insulin demand. GLP-1 medications work by enhancing glucose-dependent insulin secretion from the pancreas, slowing gastric emptying, and acting on appetite and reward centers in the brain to drive satiety, producing substantial weight loss that secondarily improves insulin sensitivity by reducing visceral adipose tissue.

The fuller picture of where GLP-1s fit in PCOS management (what the evidence supports, who they are appropriate for, the trade-offs versus metformin) is in our dedicated semaglutide for PCOS guide. For most women with PCOS-driven insulin resistance, metformin is the first pharmacological step, with GLP-1s reserved for cases that need more.

When is metformin the right tool, and when is it not?

Metformin can be the right tool when insulin resistance is the root cause of your PCOS. If you choose to use it, work with your doctor on the dose ramp and the monitoring (annual B12, periodic metabolic labs, GI tolerability adjustments), and keep the foundation in place alongside it: changing what you eat, how you move and which supplements you take is the most effective way to reverse insulin resistance and thrive with PCOS. Start with a high-protein, low-starch PCOS Repair Breakfast and cut all dessert foods and added sugars out of your diet for four weeks, which I have found to be the ideal amount of time to reverse insulin resistance and get rid of cravings and reliance on sugar.

Metformin is less helpful for women whose PCOS presentation is not metabolically driven. The adrenal subtype, where the androgen excess is being driven by DHEA from the adrenal glands rather than insulin-driven testosterone from the ovaries, does not respond to insulin sensitization the way the classic insulin-resistant subtype does. Women whose primary distress is severe hirsutism rather than cycle dysfunction or weight pattern will need targeted antiandrogen therapy on top of any metabolic work, because metformin does not move that symptom meaningfully. Take my free root cause quiz first: it tells you in a few minutes whether Insulin-Resistant, Adrenal, Post-Pill or Inflammatory PCOS is driving your symptoms. Our insulin resistance and PCOS breakdown is the starting point for working out where on the metabolic spectrum your case actually sits.

And there is one structural point worth holding onto. Unlike the combined birth control pill, which masks PCOS symptoms by artificially suppressing your brain-to-ovary communication, metformin acts on the underlying metabolic signal that is driving the condition in the first place. The mechanism it works through is the same mechanism a low-glycemic-load diet, regular movement, inositol, and (where appropriate) berberine are all acting on: lowering the insulin demand so your ovaries are not being hyper-stimulated to overproduce testosterone. Metformin is one expression of that intervention, not a category apart from it.

If you are insulin-resistant, lowering your circulating insulin is the single most leveraged thing you can do to lower your testosterone, restore your menstrual cycle, and protect your long-term metabolic and cardiovascular health. Whether you achieve that through metformin, through inositol at the 40:1 ratio, through a strict low-glycemic-load diet and consistent resistance training, or, most commonly, through some combination of those, the underlying goal is the same: take the pressure off your pancreas, and your ovaries follow.

For the full context on the metabolic-endocrine framing this whole conversation rests on, and why the medical community formally renamed the condition in 2026, see our complete guide on what the PMOS name change means for women.